Delivery Order SPE2DB20D7061-SPE2DB24FSLF5

Award Date 11/16/23
Potential Completion Date 11/17/23
Potential Value $2.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,126.15 Firm Fixed Price delivery order contract is for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has an ultimate completion date of May 2, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,659.19 firm fixed-price delivery order is for the supply of INFUVITE ADULT VIAL 10ML medical products, with a performance period ending on May 16, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
This federal contract award, valued at $15,191.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE ADULT BULK VIAL 100ML, a pharmaceutical product, with a performance period extending through October 31, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of INFUVITE PEDIATRIC VIAL 5ML medical supplies. The contract, valued at $24,836.74, is a Firm Fixed Price Delivery Order that runs through February 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award, valued at $2,529.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of INFUVITE PEDIATRIC VIAL 5ML medical supplies, with a completion date of March 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $48,445.33, is for the delivery of INFUVITE ADULT BULK VIAL 100ML medical supplies. It is a firm fixed-price delivery order contract with a completion date of March 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 4, 2025. The $8,014.00 firm-fixed-price delivery order is for the supply of INFUVITE PEDIATRIC VIAL 5ML medical products. The contract has an ultimate completion date of February 5, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of INFUVITE ADULT BULK VIAL 100ML pharmaceutical products. The $29,529.66 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds two Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of INFUVITE ADULT BULK VIAL 100ML medical products. The contract has a ceiling value of $19,288.02 and a period of performance through October 22, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that maintains an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $7,229.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFED 100 MG/2 ML VIAL 2ML, which is a specialty pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB24FSLF5
    Delivery Order

This federal contract award, with a ceiling value of $2,522.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of INFUVITE ADULT VIAL 10ML medical supplies, with an ultimate completion date of November 17, 2023.

The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC with the DLA is valued at up to $999,999,999.00 and runs through November 2026. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 5/12/25, 9:51 AM